Oct 27 (Reuters) – French drugmaker Sanofi said on Friday it was considering a separate listing of its Consumer Healthcare business from the fourth quarter of next year, as it seeks to boost the development of new drugs.
“Sanofi is studying possible separation scenarios, but believes that the route most likely to be taken would be that of an operation on the capital markets through the creation of a listed company whose headquarters would be in Paris,” Sanofi said in a statement.
(Report by Ludwig Burger; French version by Mariana Abreu, edited by Blandine Hénault)
©2023 Thomson Reuters, all rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. “Reuters” and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.